Monash IVF Group - Public Comps and Valuation Multiples

Monash IVF Group Overview

About Monash IVF Group

Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia IVF and International IVF. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia. Maximum revenue is earned from Australia IVF and Ultrasound.

Founded

2014

HQ

Employees

997

Website

monashivfgroup.com.au

Sectors

Hospitals & Clinics

Financials

LTM Revenue $177M

LTM EBITDA $42.6M

EV

$285M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Monash IVF Group Financials

As of August 2025, Monash IVF Group reported last 12-month revenue of $177M and EBITDA of $42.6M.

In the same period, Monash IVF Group generated $126M in LTM gross profit and $17.1M in net income.

See Monash IVF Group valuation multiples based on analyst estimates

Monash IVF Group P&L

In the most recent fiscal year, Monash IVF Group reported revenue of $167M and EBITDA of $7.1M.

Monash IVF Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Monash IVF Group valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$177M	XXX	$167M	XXX	XXX	XXX
Gross Profit	$126M	XXX	$150M	XXX	XXX	XXX
Gross Margin	71%	XXX	90%	XXX	XXX	XXX
EBITDA	$42.6M	XXX	$7.1M	XXX	XXX	XXX
EBITDA Margin	24%	XXX	4%	XXX	XXX	XXX
EBIT	$27.6M	XXX	-$3.7M	XXX	XXX	XXX
EBIT Margin	16%	XXX	-2%	XXX	XXX	XXX
Net Profit	$17.1M	XXX	-$4.3M	XXX	XXX	XXX
Net Margin	10%	XXX	-3%	XXX	XXX	XXX
Net Debt	XXX	XXX	$31.6M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Monash IVF Group including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $177M. EBITDA for the last twelve months was $42.6M. In the most recent fiscal year, Monash IVF Group achieved $167M in revenue and $7.1M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$177M	Analyst estimates available to subscribers	$167M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$126M	Analyst estimates available to subscribers	$150M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	71.3% gross margin	Analyst estimates available to subscribers	89.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$42.6M	Analyst estimates available to subscribers	$7.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	24.1% EBITDA margin	Analyst estimates available to subscribers	4.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$27.6M	Analyst estimates available to subscribers	-$3.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	15.6% EBIT margin	Analyst estimates available to subscribers	-2.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$17.1M	Analyst estimates available to subscribers	-$4.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	9.6% net profit margin	Analyst estimates available to subscribers	-2.6% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$31.6M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Monash IVF Group

This financial data table provides comprehensive performance metrics for Monash IVF Group, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Monash IVF Group generated $177M in revenue over the last twelve months.
The company achieved $42.6M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $126M.
Net income over the last twelve months reached $17.1M.

Fiscal Year Performance

In the most recent fiscal year, Monash IVF Group reported $167M in total revenue.
Fiscal year EBITDA was $7.1M.
The company maintained a gross profit margin of 89.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 4.2%.
Net profit margin reached -2.6% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Monash IVF Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Monash IVF Group Stock Performance

Monash IVF Group has current market cap of AUD 265M (or $174M), and EV of AUD 436M (or $285M).

Market Cap Evolution

Monash IVF Group Stock Data

As of September 19, 2025, Monash IVF Group's stock price is AUD 1 (or $0).

See Monash IVF Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$285M	$174M	XXX	XXX	XXX	XXX	$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Monash IVF Group Valuation Multiples

Monash IVF Group's trades at 1.9x EV/Revenue multiple, and 15.2x EV/EBITDA.

See valuation multiples for Monash IVF Group and 15K+ public comps

Monash IVF Group Financial Valuation Multiples

As of September 19, 2025, Monash IVF Group has market cap of $174M and EV of $285M.

Equity research analysts estimate Monash IVF Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Monash IVF Group has a P/E ratio of 10.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$174M	XXX	$174M	XXX	XXX	XXX
EV (current)	$285M	XXX	$285M	XXX	XXX	XXX
EV/Revenue	1.6x	XXX	1.9x	XXX	XXX	XXX
EV/EBITDA	6.7x	XXX	15.2x	XXX	XXX	XXX
EV/EBIT	10.3x	XXX	31.7x	XXX	XXX	XXX
EV/Gross Profit	2.3x	XXX	n/a	XXX	XXX	XXX
P/E	10.2x	XXX	34.6x	XXX	XXX	XXX
EV/FCF	119.6x	XXX	20.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Monash IVF Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Monash IVF Group Margins & Growth Rates

Monash IVF Group's last 12 month revenue growth is -2%

Monash IVF Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Monash IVF Group's rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Monash IVF Group's rule of X is 20% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Monash IVF Group and other 15K+ public comps

Monash IVF Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-2%	XXX	7%	XXX	XXX	XXX
EBITDA Margin	24%	XXX	12%	XXX	XXX	XXX
EBITDA Growth	-6%	XXX	48%	XXX	XXX	XXX
Rule of 40	11%	XXX	11%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	20%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	3%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	92%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial